Vol. 20.C January - February 2021 | Annals of Hepatology

Tienda Elsevier

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Annals of Hepatology

Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

4.4

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

9.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

1.011

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

1.057

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

portada-S1665268120X00081

Vol. 20.

(January - February 2021)

Ann Hepatol. 2021;20C:100302

Open access

Share

Editorial

Viruses and the Liver 2020: Before COVID-19 and the beginning of a new age in medicine

Arturo Panduro

Ann Hepatol. 2021;20C:100293

Open access

Share

Opinions

Mediterranean diet or genome-based nutrition diets in Latin America's clinical practice guidelines for managing chronic liver diseases?

Claudia Ojeda-Granados, Sonia Roman

Ann Hepatol. 2021;20C:100291

Open access

Share

Concise reviews

A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)

Virginia Sedeño-Monge, Saul Laguna-Meraz, Gerardo Santos-López, Arturo Panduro, Francisca Sosa-Jurado, Alexis Jose-Abrego, Daniel Meléndez-Mena, Marco A. Muñoz-Ramírez, ... Sonia Roman

Ann Hepatol. 2021;20C:100292

Open access

Share

Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis

Sahaj Rathi, Trana Hussaini, Eric M. Yoshida

Ann Hepatol. 2021;20C:100211

Open access

Share

Liquid biopsy in chronic liver disease

Hugo A. Barrera-Saldaña, Luis E. Fernández-Garza, Silvia A. Barrera-Barrera

Ann Hepatol. 2021;20C:100197

Open access

Share

Original articles

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

Ivan Lopez-Mendez, Jorge Aquino-Matus, Sofia Murua-Beltrán Gall, Jose D. Prieto-Nava, Eva Juarez-Hernandez, Misael Uribe, Graciela Castro-Narro

Ann Hepatol. 2021;20C:100271

Open access

Open Article

Share

LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway

Tao Wan, Jun Zheng, Rucheng Yao, Shuang Yang, Weihong Zheng, Pei Zhou

Ann Hepatol. 2021;20C:100258

Open access

Share

Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1–6 in Brazil

Mario Peribañez-Gonzalez, Hugo Cheinquer, Lino Rodrigues, Maria Patelli Lima, Mário Reis Álvares-da-Silva, José Madruga, Edison Roberto Parise, Mário Guimarães Pessoa, ... Tania Reuter

Ann Hepatol. 2021;20C:100257

Open access

Share

Cost of illness of liver diseases in Japan

Kunichika Matsumoto, Yinghui Wu, Shigeru Fujita, Kanako Seto, Yosuke Hatakeyama, Ryo Onishi, Tomonori Hasegawa

Ann Hepatol. 2021;20C:100256

Highlights

•
The COI of liver diseases in Japan has been decreasing for the past 15 years.
•
The COI of hepatitis C continued to decline despite the advent of expensive drugs.
•
The emergence of effective DAAs is expected to reduce the COI of all liver diseases.

Open access

Share

The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies

Umar Hayat, Ali A. Siddiqui, Hayrettin Okut, Saba Afroz, Syed Tasleem, Ahmed Haris

Ann Hepatol. 2021;20C:100254

Open access

Share

Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease

José Tadeu Stefano, Laura Vilar Guedes, Arthur Alencar Arrais de Souza, Denise Siqueira Vanni, Venâncio Avancini Ferreira Alves, Flair José Carrilho, Alvaro Largura, Marco Arrese, Claudia P. Oliveira

Ann Hepatol. 2021;20C:100253

Open access

Share

Clinical evaluation of modified ALPPS procedures based on risk-reduced strategy for staged hepatectomy

Jie Li, Guang-Sheng Yang, Ke-Jian Sun, Yan Ma, Xiao-Wang Bi, Xu Han

Ann Hepatol. 2021;20C:100245

Open access

Share

PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population

Danil I. Peregud, Valeria Yu. Baronets, Anna S. Lobacheva, Alexandr S. Ivanov, Olga S. Arisheva, Irina V. Garmash, Zhanna D. Kobalava, Sergey V. Pirozhkov, Natalia N. Terebilina

Ann Hepatol. 2021;20C:100247

Open access

Share

Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study

Zeyuan Qiang, Wenhua Zhang, Shuai Jin, Kunfu Dai, Yuting He, Lianyuan Tao, Haibo Yu

Ann Hepatol. 2021;20C:100242

Open access

Share

Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling

Shuxia Tian, Min Chen, Bing Wang, Yonglong Han, Haonan Shang, Junming Chen

Ann Hepatol. 2021;20C:100259

Open access

Share

Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease

Humberto O. Galizzi, Claudia A. Couto, Daniela O.L. Taranto, Samuel I.O. Araújo, Eduardo G. Vilela

Ann Hepatol. 2021;20C:100229

Open access

Share

Case report

Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case report

Samantha Thifani Alrutz Barcelos, Vincent Marin Dall’Oglio, Alexandre de Araújo, Carlos Thadeu Schmidt Cerski, Mário Reis Álvares-da-Silva

Ann Hepatol. 2021;20C:100138

Open access

Share

Preserving the organ donor pool and suprahepatic vena cava: Case series of transverse hepatectomy for polycystic liver disease

Thomas W. Smith, Ari Goldberg, Amy D. Lu

Ann Hepatol. 2021;20C:100118

Open access

Share